| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 536,990 | 548,866 | 604,702 | 589,131 |
| Cost of goods sold | 336,109 | 340,802 | 394,593 | 384,279 |
| Gross profit | 200,881 | 208,064 | 210,109 | 204,852 |
| Selling, general and administrative | 152,773 | 159,392 | 157,233 | 162,707 |
| Research and development | 21,251 | 21,867 | 23,291 | 21,028 |
| Restructuring, strategic transaction and integration | 13,138 | 16,218 | 16,697 | 16,828 |
| Change in fair value of contingent earn-out | 0 | 0 | - | -3,947 |
| Total operating expenses | 187,162 | 197,477 | 197,221 | 196,616 |
| Income (loss) from operations | 13,719 | 10,587 | 12,888 | 8,236 |
| Interest expense,net | 19,808 | 20,549 | 22,031 | 24,683 |
| Other income (expense), net | 607 | 1,818 | -1,763 | -1,481 |
| Gain on sale of business | 2,969 | 41,823 | - | - |
| Income (loss0 before income taxes and equity in earnings of unconsolidated affiliates | -2,513 | 33,679 | -10,906 | -17,928 |
| Provision for income taxes | -658 | 1,178 | 4,570 | 15,055 |
| Provision for income taxes-Operating Segments | - | 1,178 | - | - |
| Net income (loss) from consolidated companies | -1,855 | 32,501 | - | - |
| Equity in earnings of unconsolidated affiliates | -1,541 | 2,837 | - | - |
| Net income (loss) | -3,396 | 35,338 | -15,476 | -32,983 |
| Basic (in dollars per share) | -0.14 | 1.43 | -0.63 | -1.35 |
| Basic (in shares) | 24,686,000 | 24,645,000 | 24,539,000 | 24,438,000 |
| Diluted (in dollars per share) | -0.14 | 1.43 | -0.63 | -1.35 |
| Diluted (in shares) | 24,686,000 | 24,708,000 | 24,539,000 | 24,438,000 |
ICU MEDICAL INC DE (ICUI)
ICU MEDICAL INC DE (ICUI)